A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation

M M Kim1, M A Rivera, I L Botchkina

  • 1Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-0448, USA.

Insights

Introducing a novel cancer therapy, this study shows that expressing mutant-template telomerase RNAs in cancer cells inhibits tumor growth and proliferation. This telomerase-based strategy offers a promising new avenue for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Telomerase is a ribonucleoprotein enzyme essential for synthesizing telomeric DNA.
  • Telomerase activity is frequently upregulated in various cancer cells, contributing to their uncontrolled proliferation.
  • Targeting telomerase presents a potential strategy for cancer therapy.

Purpose of the Study:

  • To investigate the potential of expressing mutant-template telomerase RNAs as an antitumor strategy.
  • To evaluate the effect of mutant-template telomerase RNA expression on cancer cell viability, apoptosis, and tumor growth.

Main Methods:

  • Expression of mutant-template human telomerase RNAs in human prostate (LNCaP) and breast (MCF-7) cancer cell lines.
  • Assessment of cellular viability and apoptosis following expression of mutant telomerase RNAs.
  • Evaluation of tumor xenograft growth rates in vivo in mice bearing cancer cells expressing mutant telomerase RNA.

Main Results:

  • Low-level expression of mutant-template telomerase RNAs, but not wild-type, significantly decreased cancer cell viability and increased apoptosis.
  • These effects occurred independently of endogenous telomerase activity and telomere length.
  • In vivo studies demonstrated reduced tumor growth rates in xenografts expressing mutant-template telomerase RNA.

Conclusions:

  • Mutant-template telomerase RNAs exert a dominant-negative effect on cancer cell proliferation and tumor growth.
  • This approach shows potential as a novel antineoplastic strategy.
  • Further research into mutant-template telomerase RNA expression is warranted for cancer treatment development.

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...